| Maryha Javed, | |
|
1701 E 23rd Ave, Hutchinson, KS 67502-9907 | |
| (620) 665-2000 | |
| (620) 665-2137 |
| Full Name | Maryha Javed |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 9 Years |
| Location | 1701 E 23rd Ave, Hutchinson, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235662826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 04-43861 (Kansas) | Primary |
| 207R00000X | Internal Medicine | 04-43861 (Kansas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Santa Rosa Memorial Hospital | Santa rosa, CA | Hospital |
| Hutchinson Regional Medical Center Inc | Hutchinson, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hutchinson Physicians Pa | 4183941818 | 20 |
| Providence Medical Foundation | 8921993205 | 1293 |
News Archive
The COVID-19 pandemic is having a profound, negative impact on nine out of ten people with experience of eating disorders, a new study from Northumbria University, Newcastle, reveals.
German scientists used DNA nanolevers to target the interaction between a peptide known as PeB and influenza A.
Pharmasset, Inc. announced today interim efficacy and safety results from its ongoing 28-day phase 2a study with PSI-7977 dosed once daily in combination with Pegasys® (peginterferon alfa 2a) and Copegus® (ribavirin) in patients with hepatitis C virus (HCV) genotype 1 who have not been treated previously.
Amid growing protests from opponents of health care reform, the majority of middle-class Americans are expressing concern about paying for medical costs during retirement – and dramatically underestimating the financial burden they'll be expected to bear.
› Verified 7 days ago
| Entity Name | Hutchinson Physicians Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427459684 PECOS PAC ID: 4183941818 Enrollment ID: O20150318000228 |
News Archive
The COVID-19 pandemic is having a profound, negative impact on nine out of ten people with experience of eating disorders, a new study from Northumbria University, Newcastle, reveals.
German scientists used DNA nanolevers to target the interaction between a peptide known as PeB and influenza A.
Pharmasset, Inc. announced today interim efficacy and safety results from its ongoing 28-day phase 2a study with PSI-7977 dosed once daily in combination with Pegasys® (peginterferon alfa 2a) and Copegus® (ribavirin) in patients with hepatitis C virus (HCV) genotype 1 who have not been treated previously.
Amid growing protests from opponents of health care reform, the majority of middle-class Americans are expressing concern about paying for medical costs during retirement – and dramatically underestimating the financial burden they'll be expected to bear.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maryha Javed, 2101 N Waldron St, Hutchinson, KS 67502-1131 Ph: (620) 694-4194 | Maryha Javed, 1701 E 23rd Ave, Hutchinson, KS 67502-9907 Ph: (620) 665-2000 |
News Archive
The COVID-19 pandemic is having a profound, negative impact on nine out of ten people with experience of eating disorders, a new study from Northumbria University, Newcastle, reveals.
German scientists used DNA nanolevers to target the interaction between a peptide known as PeB and influenza A.
Pharmasset, Inc. announced today interim efficacy and safety results from its ongoing 28-day phase 2a study with PSI-7977 dosed once daily in combination with Pegasys® (peginterferon alfa 2a) and Copegus® (ribavirin) in patients with hepatitis C virus (HCV) genotype 1 who have not been treated previously.
Amid growing protests from opponents of health care reform, the majority of middle-class Americans are expressing concern about paying for medical costs during retirement – and dramatically underestimating the financial burden they'll be expected to bear.
› Verified 7 days ago